Advocacy intelligence hub — real-time data for patient organizations
InnoVec Biotherapeutics Inc. — EARLY_PHASE1
West China Hospital — EARLY_PHASE1
Atsena Therapeutics Inc. — PHASE1, PHASE2
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Fang Lu
Department of Ophthalmology, West China Hospital, Sichuan University
Laryssa A Huryn, M.D., RPh
National Eye Institute (NEI)
📍 NEW YORK, NY
Camiel JF Boon, Prof. dr.
Amsterdam UMC
Amy E Turriff
National Eye Institute (NEI)
Theresa Heah, MD
Applied Genetics Technologies Corporation
Todd Durham, PhD
Senior Vice President, Clinical and Outcomes Research